Direct muscarinic cholinergic inhibition of hepatic glucose production in humans.

To explore the potential role of the parasympathetic nervous system in human glucoregulatory physiology, responses to the muscarinic cholinergic agonist bethanechol (5.0 mg s.c.) and antagonist atropine (1.0 mg i.v.) were measured in normal humans. There were no changes in the plasma glucose concentration or rates of glucose production or utilization following atropine administration. After bethanechol administration there were no changes in the plasma glucose concentration or fluxes despite increments in plasma glucagon (75 +/- 7 to 103 +/- 10 pg/ml, P less than 0.02). There were no changes in insulin or C-peptide levels. To test the hypothesis that direct muscarinic inhibition of glucose production was offset by an indirect action of the agonist, specifically increased glucagon secretion with consequent stimulation of glucose production, bethanechol was administered while glucagon levels were held constant with the islet clamp technique (somatostatin infusion with insulin, glucagon and growth hormone replacement at fixed rates). Under that condition the muscarinic agonist induced a 25% decrement in the plasma glucose concentration (101 +/- 8 to 75 +/- 8 mg/dl, P less than 0.05). When compared with separate clamp control studies (with placebo rather than bethanechol injection) both the rate of glucose production and the glucose concentration were reduced (P less than 0.05) following bethanechol injection; the rate of glucose utilization was unaltered. Thus, we conclude: Withdrawal of parasympathetic tone does not appear to be an important glucoregulatory process in humans. Direct muscarinic cholinergic inhibition of hepatic glucose production occurs in humans but during generalized muscarinic activation this is offset by an indirect muscarinic action, increased glucagon secretion with consequent stimulation of glucose production. Thus, particularly if regional neuronal firing occurs, the parasympathetic nervous system may play an important role in human glucoregulatory physiology.

[1]  R. Rizza,et al.  Regulation of glucose metabolism by sympathochromaffin catecholamines. , 1988, Diabetes/metabolism reviews.

[2]  P. Cryer,et al.  Epinephrine is not critical to prevention of hypoglycemia during exercise in humans. , 1986, The American journal of physiology.

[3]  K. Jungermann,et al.  Control of glucose balance in the perfused rat liver by the parasympathetic innervation. , 1986, Biological chemistry Hoppe-Seyler.

[4]  P. Cryer,et al.  Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion. , 1986, The Journal of clinical investigation.

[5]  P. Cryer,et al.  External and internal standards in the single-isotope derivative (radioenzymatic) measurement of plasma norepinephrine and epinephrine. , 1985, The Journal of laboratory and clinical medicine.

[6]  M. Entman,et al.  Effects of atropine and gastric inhibitory polypeptide on hepatic glucose uptake and insulin extraction in conscious dogs. , 1985, The Journal of clinical investigation.

[7]  P. Cryer,et al.  Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans. , 1985, The Journal of clinical investigation.

[8]  W. Lautt,et al.  Afferent and efferent neural roles in liver function , 1983, Progress in Neurobiology.

[9]  T. Schwartz,et al.  Pancreatic polypeptide: a hormone under vagal control. , 1983, Gastroenterology.

[10]  J. Ensinck,et al.  Immunoassays for Glucagon , 1983 .

[11]  R. Miller,et al.  Pancreatic neuroendocrinology: peripheral neural mechanisms in the regulation of the Islets of Langerhans. , 1981, Endocrine reviews.

[12]  J. Ratcliffe,et al.  AUTONOMIC NEURAL CONTROL MECHANISMS OF SUBSTRATE and HORMONAL RESPONSES TO ACUTE HYPOGLYCAEMIA IN MAN , 1981, Clinical endocrinology.

[13]  P. Cryer,et al.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. , 1980, The Journal of clinical investigation.

[14]  W. Lautt.  Hepatic nerves: a review of their functions and effects. , 1980, Canadian journal of physiology and pharmacology.

[15]  P. Cryer,et al.  Cholinergic stimulation of norepinephrine release in man. Evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy. , 1979, The Journal of clinical investigation.

[16]  R. Rizza,et al.  Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. , 1979, The Journal of clinical investigation.

[17]  J. Palmer,et al.  Evaluation of the control of glucagon secretion by the parasympathetic nervous system in man. , 1979, Metabolism: Clinical and Experimental.

[18]  P. Cryer,et al.  Adrenergic mechanisms in recovery from hypoglycemia in man: adrenergic blockade. , 1979, The American journal of physiology.

[19]  P. Lacy,et al.  Regional Pancreatic Concentration and In-vitro Secretion of Canine Pancreatic Polypeptide, Insulin, and Glucagon , 1978, Diabetes.

[20]  D L Horwitz,et al.  Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.

[21]  R W Farmer,et al.  Plasma cortisol determination: radioimmunoassay and competitive protein binding compared. , 1974, Clinical chemistry.

[22]  A. Jennings,et al.  Cholinergic modification of glucose-induced biphasic insulin release in vitro. , 1974, The Journal of clinical investigation.

[23]  A. Esterhuizen,et al.  Nature of Islet-cell Innervation in the Cat Pancreas , 1968, Diabetes.

[24]  J. Watson,et al.  Enzymic assay of glycerol, dihydroxyacetone, and glyceraldehyde. , 1967, Archives of biochemistry and biophysics.

[25]  L. Frohman,et al.  Effect of Vagotomy and Vagal Stimulation on Insulin Secretion , 1967, Diabetes.

[26]  R. Steele,et al.  Glucose metabolism and plasma insulin level during epinephrine infusion in the dog. , 1967, The American journal of physiology.

[27]  D. Kipnis,et al.  Hormone-fuel interrelationships during fasting. , 1966, The Journal of clinical investigation.

[28]  M. Novak.  COLORIMETRIC ULTRAMICRO METHOD FOR THE DETERMINATION OF FREE FATTY ACIDS. , 1965, Journal of lipid research.

[29]  O. H. Lowry,et al.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. , 1964, The Journal of biological chemistry.

[30]  L. Goodman,et al.  The Pharmacological Basis of Therapeutics , 1941 .